The Ebola outbreak in West Africa eventually could exceed 20,000 cases, more than six times as many as are known now, the World Health Organization said Thursday as the United States announced plans to test an experimental Ebola vaccine.
GENEVA — The Ebola outbreak in West Africa eventually could exceed 20,000 cases, more than six times as many as are known now, the World Health Organization said Thursday as the United States announced plans to test an experimental Ebola vaccine.
Currently, about half of the people infected with Ebola have died, so in a worst-case scenario the death toll could reach 10,000, the agency said, according to a plan released Thursday on how to stop the outbreak.
The U.N. agency's latest figures show that 1,552 people have died from the virus from among the 3,069 cases reported so far in Liberia, Sierra Leone, Guinea and Nigeria. However, it said the actual number of cases in many hard-hit areas may be two to four times higher than that. That suggests there could be up to 12,000 cases already.
"This far outstrips any historic Ebola outbreak in numbers. The largest outbreak in the past was about 400 cases," Dr. Bruce Aylward, WHO's assistant director-general for emergency operations, told reporters.
More than 40 percent of the cases have been identified in the last three weeks, the U.N. health agency said, adding that "the outbreak continues to accelerate." Aylward said the agency does not necessarily expect 20,000 cases, but a system must be put into place to handle such a massive increase in case numbers.
The U.S. National Institutes of Health, meanwhile, announced it will start testing an experimental Ebola vaccine in humans next week. The vaccine was developed by the U.S. government and GlaxoSmithKline and the preliminary trial will test the shot in healthy U.S. adults in Maryland. At the same time, British experts will test the same vaccine in healthy people in the U.K., Gambia and Mali.
The vaccine trial was accelerated in response to the outbreak that has ravaged West Africa and led to riots as poorly designed quarantines were put into place against tens of thousands of people.
Preliminary results to determine if the vaccine is safe could be available within months.
Aylward said the current outbreak was posing a unique challenge because there are multiple hotspots in several countries, including some in densely populated urban areas. Previous outbreaks had happened in a single, remote area.
The new plan aims to stop Ebola transmission in affected countries within six to nine months and prevent it from spreading internationally. It calls for $489 million over the next nine months and requires 750 international health workers and 12,000 national ones.
The goal is to take "the heat out of this outbreak" within three months, Aylward said. The next goal would be to stop the transmission of the killer virus within eight weeks of a new case being confirmed anywhere in the world.
The third major goal is to increase the preparedness for dealing with Ebola in all nations that share borders with affected countries or have major transportation hubs, he said.
Doctors Without Borders, a charity that has criticized the WHO and the international community for responding too slowly to the crisis, warned that the new U.N. plan "should not give a false sense of hope."